A review of 6 novel drugs approved by the FDA, with links to coverage from Contemporary Pediatrics and other MJH brands. Multiple strides in pediatric care have been reported so far in 2026, marking a ...

Explore essential resources and toolkits for managing the ongoing stimulant medication shortage affecting ADHD treatment and patient care. Drug shortages have historically led to economic impacts, ...

Switching to donidalorsen led to a 67.6% reduction in monthly HAE attack rates over 1 year, with consistent benefit across prior prophylactic therapies. Most patients achieved or maintained ...

Long-acting injectable HIV treatment given every 2 months was safe, well tolerated, and strongly preferred by adolescents in a recent study. Maternal influenza and TDaP vaccination during pregnancy ...

The latest update to the HEEADSSS psychosocial interview for adolescents includes new questions on electronic media use in addition to its time-tested strategies for identifying the critical stressors ...

Discover mental health screening tools for the pediatric primary care provider. The National Association of Pediatric Nurse Practitioners called to prioritize integrating pediatric mental health into ...

GLP-1 receptor agonists, used to treat diabetes, are now also being used for obesity in children and adolescents. Pediatric obesity affects more than 14 million children, which is equivalent to 1 in 5 ...

Finding an acceptable alternative to breast milk has proved to be a complicated quest that continues today. Finding an acceptable alternative to breast milk has proved to be a complicated quest that ...

The mother of a 5-week-old boy was concerned about a swelling under her infant’s right nipple. A 2-cm, movable subareolar mass was palpated on examination. The mother of a 5-week-old boy was concerned ...

Not forcing affection, using appropriate language, and controlling media exposure are just some of the American Academy of Pediatrics’ tips for teaching children about body boundaries and safety.

The approved indication now includes children down to 6 weeks of age to protect against invasive meningococcal disease via serogroups A, C, W, and Y. On May 23, 2025, the FDA approved an expanded ...

Read the latest medications for pediatric patients approved by the US Food and Drug Administration.